Mary-Jane Burkett
Director of Finance/CFO chez NUVO PHARMACEUTICALS INC.
Profil
Mary-Jane E.
Burkett is currently the Chief Financial Officer & Vice President at Nuvo Pharmaceuticals, Inc. She started this position in 2016.
Prior to her current role, she worked as a Controller at Crescita Therapeutics, Inc. Ms. Burkett completed her undergraduate degree at Richard Ivey School of Business.
Postes actifs de Mary-Jane Burkett
| Sociétés | Poste | Début |
|---|---|---|
| NUVO PHARMACEUTICALS INC. | Director of Finance/CFO | 01/09/2016 |
Anciens postes connus de Mary-Jane Burkett
| Sociétés | Poste | Fin |
|---|---|---|
| CRESCITA THERAPEUTICS INC. | Comptroller/Controller/Auditor | - |
Formation de Mary-Jane Burkett
| Richard Ivey School of Business | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
